Clinical Trials Directory

Trials / Unknown

UnknownNCT05977543

Acute Effect of Functional Crackers on Postprandial Metabolism

The Acute Effect of Functional Crackers, Enriched With Grape Seed Flour or With Barley Flour and β-glucans, on Postprandial Glycemic, Lipemic and Antioxidant Metabolism

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of the Aegean · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this interventional study was to investigate the postprandial effect of two types of functional crackers, with 10% grape seed flour or 40% barley flour, enriched with β-glucan, in metabolic biomarkers of healthy participants.

Detailed description

A pilot cross-over, controlled, randomized and single-blinded, intervention-clinical trial was carried out, in twelve healthy men and women, aged nineteen to sixty-five years, after random allocation into the control, the grape and the barley interventional groups, received a high-fat and high-carbohydrate meal, containing wheat flour or wheat and 10% grape seed flour or wheat and 40% barley flour, enriched with β-glucan, crackers. Participants consumed the same meals, allocating in cross-over order, with 1 washout week after each trial period. Differences on the metabolism of postprandial serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.

Conditions

Interventions

TypeNameDescription
OTHERFunctional crackers enriched with grape seed flourThe crackers was enriched with 10% grape seed flour
OTHERFunctional crackers with 40% barley flour and enriched with β-glucansThe crackers consisted of 60% wheat flour, 40% barley flour and was enriched with β-glucans.

Timeline

Start date
2023-02-15
Primary completion
2023-10-01
Completion
2024-01-15
First posted
2023-08-04
Last updated
2023-11-30

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05977543. Inclusion in this directory is not an endorsement.